we provide a medical home
SGLT2is, and GLP-1 RAs in particular promote weight loss, and therefore especially may be of benefit, given that overweight and obesity is increasingly prevalent (62%) in individuals with type 1 diabetes [12]
Is that risk big enough that should factor into the conversation about whether these drugs would be useful to the individual
This is still an investigational mechanism, meaning it has not been confirmed through years of real world use, only through controlled trials
This flexibility, when used appropriately, can prevent missed doses without compromising treatment efficacy
It is a synthetic version of Epihalamine, a peptide extract of the pineal gland developed in Russia in the 1980s